ABAXIS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-11-18: Reporting owner Henkel Achim; Form 4; Security Option Exercise; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-06: Reporting owner HANLON BRENTON; Form 4; Security Option Exercise; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-06: Reporting owner HANLON BRENTON; Form 4; Security Option Exercise; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-06: Reporting owner HANLON BRENTON; Form 4; Security Option Exercise; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-11-18 | Henkel Achim Officer (Managing Director-Europe) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 5,000 owned after | $7.88 exercise price | 2010-01-20 | |
| 2009-11-06 | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $12.28 exercise price | 2009-11-06 | |
| 2009-11-06 | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $19.65 exercise price | 2009-11-06 | |
| 2009-11-06 | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $6.41 exercise price | 2009-11-06 | |
| 2009-11-06 | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $4.75 exercise price | 2009-11-06 | |
| 2009-10-30 holding as of filing | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 3 | Stock Options Derivative · Direct | Holding | $4.75 exercise price | 2009-10-30 | ||
| 2009-10-30 holding as of filing | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 3 | Stock Options Derivative · Direct | Holding | $6.41 exercise price | 2009-10-30 | ||
| 2009-10-30 holding as of filing | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 3 | Stock Options Derivative · Direct | Holding | $19.65 exercise price | 2009-10-30 | ||
| 2009-10-30 holding as of filing | HANLON BRENTON Officer (VP-Sales & Marketing,Medical) | 3 | Stock Options Derivative · Direct | Holding | $12.28 exercise price | 2009-10-30 | ||
| 2009-09-03 | BASTIANI RICHARD Director | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $4.13 exercise price | 2009-09-03 | |
| 2009-08-10 | ARON KENNETH Officer (Chief Technology Officer) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,109 0 owned after | $7.56 exercise price | 2009-08-11 | |
| 2009-02-19 | OSTOICH VLADIMIR Officer (VP of Govt Affairs & Pac Rim) | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $2.25 exercise price | 2009-02-20 | |
| 2009-02-11 | HANLON BRENTON Director | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $4.22 exercise price | 2009-02-12 | |
| 2009-02-05 | HANLON BRENTON Director | 4 | Option Exercise Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $4.14 exercise price | 2009-02-09 |